ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
VanEck Biotech ETF

VanEck Biotech ETF (BBH)

158.52
1.48
(0.94%)
Closed January 05 3:00PM
159.0894
0.5694
(0.36%)
After Hours: 6:59PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
158.52
Bid
142.21
Ask
175.00
Volume
4,696
157.57 Day's Range 159.0894
151.35 52 Week Range 183.6449
Market Cap
Previous Close
157.04
Open
157.68
Last Trade
2
@
158.52
Last Trade Time
Financial Volume
US$ 745,410
VWAP
158.7329
Average Volume (3m)
9,152
Shares Outstanding
2,547,000
Dividend Yield
-
PE Ratio
6.55
Earnings Per Share (EPS)
24.28
Revenue
4.09M
Net Profit
61.84M

About VanEck Biotech ETF

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the funds benchmark index. The Biotech Index includes com... The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the funds benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified. Show more

Sector
Mgmt Invt Offices, Open-end
Industry
Mgmt Invt Offices, Open-end
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
VanEck Biotech ETF is listed in the Mgmt Invt Offices, Open-end sector of the NASDAQ with ticker BBH. The last closing price for VanEck Biotech ETF was US$157.04. Over the last year, VanEck Biotech ETF shares have traded in a share price range of US$ 151.35 to US$ 183.6449.

VanEck Biotech ETF currently has 2,547,000 shares outstanding. The market capitalization of VanEck Biotech ETF is US$399.98 million. VanEck Biotech ETF has a price to earnings ratio (PE ratio) of 6.55.

BBH Latest News

VanEck Announces Year-End Distributions for VanEck Equity ETFs

VanEck announced today the following 2024 annual distributions per share for its VanEck® equity exchange-traded funds. Distributions Per Share for the VanEck ETFs Listed Below Ex-Date: December...

VanEck Announces Year-End Distributions for VanEck Equity ETFs

VanEck announced today the following 2023 annual distributions per share for its VanEck® equity exchange-traded funds. Distributions Per Share for the VanEck ETFs Listed Below Ex-Date: December...

VanEck Launches Robotics ETF (IBOT)

IBOT offers global exposure to the rise of the robotics industry, which is projected to grow to over $90B by 2026.1 IBOT joins VanEck’s forward-looking thematic ETFs lineup, providing a way for...

VanEck Announces Preliminary Yearend Distribution Estimates for VanEck Vectors Equity ETFs

VanEck announced today preliminary yearend distribution estimates for its VanEck Vectors® equity exchange-traded funds. Please note that these yearend estimates were made as of October...

VanEck to Ring The Nasdaq Stock Market Opening Bell

ADVISORY, Sept. 12, 2016 (GLOBE NEWSWIRE) -- What:VanEck, a pioneer in global markets and experienced provider of innovative solutions, will visit the Nasdaq MarketSite in Times Square...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.680.430816016219157.84159.3214155.4118221156.92849544SP
4-8.48-5.07784431138167168.585154.3713324159.41860489SP
12-18.1-10.2479900351176.62178.9519154.379152163.51064715SP
26-9.82-5.83343233931168.34183.6449154.376925169.00163441SP
52-10.14-6.01209533974168.66183.6449151.357374166.69483693SP
156-30.43-16.1047896269188.95188.95131.11512062157.96577508SP
26021.2815.5056834742137.24223.19112.0315458163.28826922SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DIAMStar Diamond Corporation
$ 0.025
(25.00%)
17.1k
CSCICOSCIENS Biopharma Inc
$ 4.80
(22.14%)
11.2k
DII.BDorel Industries Inc
$ 4.88
(20.49%)
33.64k
ORVOrvana Minerals Corp
$ 0.28
(16.67%)
104.72k
YRBYorbeau Resources Inc
$ 0.04
(14.29%)
671k
FLNTFlint Corporation
$ 0.025
(-16.67%)
17k
RTGRTG Mining Inc
$ 0.03
(-14.29%)
544.49k
TWMTidewater Midstream and Infrastructure Ltd
$ 0.15
(-11.76%)
541.46k
EXROExro Technologies Inc
$ 0.13
(-10.34%)
676.19k
ASTLAlgoma Steel Group Inc
$ 12.92
(-7.58%)
196.97k
TDToronto Dominion Bank
$ 77.79
(1.69%)
17.95M
VRNVeren Inc
$ 7.48
(-1.32%)
6.26M
CNQCanadian Natural Resources Ltd
$ 45.61
(0.95%)
4.64M
ACAir Canada
$ 22.31
(-0.13%)
3.84M
BBBlackBerry Limited
$ 5.34
(-3.09%)
3.79M

Discussion

View Full Feed
axelvento axelvento 22 minutes ago
Q1 the first interim analysis of the vaccine’s efficacy is expected

Moderna’s mRNA-1647
Cytomegalovirus
MRNA
MightyX MightyX 25 minutes ago
Yet no one is innocent
TPTW
BIG D 4 BIG D 4 26 minutes ago
WOW !! HAPPY NEW YEAR TO ALL THE LONGS HERE !! I HAVE 2 NAYSAYERS ON IGNORE SO I NEVER READ THEIR BS !! GO SAVING GRACE-- JJ AND ALL THE NEW POSTERS WHO ARE POSITIVE !! .02 CENTS TO START THE RUN TO ONE DOLLAR IS WHERE WE SHOULD BE !! THIS STOCK IS SUCH A GREAT BUY HERE !! I AM LOADED WITH 32 MILLI
MJNA
MightyX MightyX 26 minutes ago
The judicial system legitimizes prosecution
TPTW
jondoeuk jondoeuk 27 minutes ago
A new paper. From it: 'BNT221 was well tolerated across both DLs, with no dose-limiting toxicities of grade 3 or higher attributed to the T cell product observed. Specifically, no cytokine release, immune effector cell-associated neurotoxicity or macrophage activation syndromes were reported. A dose
BNTX
benz280c benz280c 28 minutes ago
Nice to see you are bullish. This quote may round out your knowledge.
"It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
GDVM
shajandr shajandr 29 minutes ago
Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
Lakota-45 Lakota-45 30 minutes ago
Will do, but I doubt they will listen !!!

~ Lol !!!
IONI
boi568 boi568 31 minutes ago
Probably
AVXL
HokieHead HokieHead 33 minutes ago
Wrong..
TWOH
HokieHead HokieHead 34 minutes ago
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 35 minutes ago
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 37 minutes ago
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 37 minutes ago
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 38 minutes ago
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX
HomerRomer HomerRomer 38 minutes ago
More testimony videos from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed w
AVXL
CaptHowdy CaptHowdy 39 minutes ago
That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
GRLT
crescentmotor crescentmotor 40 minutes ago
I think that is a bad precedent to start.

100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
AVXL JPM
Steady_T Steady_T 42 minutes ago
MABS are the current standard of care, so Blarcamesine has to be better than the MABS, which is not saying much.

I suspect that if Blarcamesine was the equal of the MABS is would still be approved on safety and cost grounds.

As has been pointed out multiple times on the
AVXL
facts_matter14 facts_matter14 44 minutes ago
Looks like Baggy is worried about Maxine not showing up at CES this week…………….









.
SRMX
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 44 minutes ago
Anavex has delayed PD in order to wait out the development of a reliable biomarker, which has happened only during the past few months.

OK so we should see the test start this quarter then?
AVXL
Canna_Business Canna_Business 44 minutes ago
$FKINX $IONQ $FFALX $MRMD $RKLB $XOM $DUK $LNVGY $V $SOFI $BICEY $VOO $TEMWX
BICEY DUK FFALX
mrfence mrfence 44 minutes ago
Actually, these issues traded on the NYSE under conservatorship and the FHFA made a decision to voluntarily delist Fannie and Freddie from the NYSE. There's Companies in bankruptcy like Gamestop, GME, trading on Big Boards. Unfortunately, the ball's in Gooberment's as to when they see fit to up lis
GME

Your Recent History

Delayed Upgrade Clock